Hyperfine Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2026 to a ratio of 3.01, above the company average. This is a clear sign of healthy business climate in the Medical Equipment & Supplies industry and improving liquidity at their respective customers, during the third quarter 2026. Average receivable collection period, for the Hyperfine Inc in Sep 30 2026 quarter, has decreased to 121 days, compared to 144 days, in the Jun 30 2026 quarter.

If we take a look into Healthcare sector 502 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2026 from 2156 to 3333.

What is Receivable Turnover Ratio?
What is Hyperfine Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

HYPR Receivables Turnover Ratio	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Receivable Change	2.93 %	-16.69 %	-20.23 %	-21.47 %	-30.39 %
Y / Y Revenue Change	109.27 %	67.7 %	58.2 %	48.82 %	-2.06 %
Receivable Turnover Ratio (TTM)	3.01	2.53	2.17	1.89	1.51
HYPR's Total Ranking	# 3333	# 2156	# 2620	# 2637	#
Accounts Receivable average collection period days	121	144	169	194	242
Seq. Receivable Change	12.18 %	-0.14 %	-11.12 %	3.38 %	-9.21 %
Seq. Revenue Change	52.66 %	31.05 %	-47.68 %	99.93 %	22.34 %

Receivable Turnover Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 175
Healthcare Sector	# 503
Overall Market	# 3333

Receivable Turnover Ratio Statistics
High	Average	Low
3.17	2.12	1.39
(Sep 30 2022)		(Jun 30 2025)

HYPR Company Profile • Back to HYPR Efficiency Comparisons • Compare HYPR Receivables Turnover Ratio to its Competitors

Financial Statements
Hyperfine Inc 's Accounts Receivable	$ 6 Millions	Visit HYPR's Balance sheet
Hyperfine Inc 's Sales TTM	$ 19 Millions	Visit HYPR's Income Statement
Sources of HYPR's Revenues		Visit HYPR's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
HYPR's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
HYPR's Growth Rates	HYPR's Roa	HYPR's Inventory Turnover Ratio	HYPR's Dividend Comparisons
HYPR's Profitability Ratios	HYPR's Roi	HYPR's Asset Turnover Ratio	HYPR's Dividend Growth
HYPR's Valuation Ratios	HYPR's Roe	HYPR's Financial Strength Ratios	HYPR's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2026	Receivable at quarter ending Sep 30 2026
Koru Medical Systems Inc	7.84	$ 46.272 Millions	$ 5.901 Millions
Henry Schein Inc	7.84	$ 13,734.000 Millions	$ 1,752.000 Millions
Trisalus Life Sciences Inc	7.78	$ 47.397 Millions	$ 6.090 Millions
Idexx Laboratories Inc	7.78	$ 4,663.675 Millions	$ 599.701 Millions
Anteris Technologies Global Corp	7.73	$ 2.332 Millions	$ 0.302 Millions
Madrigal Pharmaceuticals Inc	7.70	$ 1,427.940 Millions	$ 185.380 Millions
Lemaitre Vascular Inc	7.66	$ 269.938 Millions	$ 35.235 Millions
Seer Inc	7.62	$ 14.248 Millions	$ 1.871 Millions
Pulmonx Corporation	7.56	$ 89.176 Millions	$ 11.791 Millions
Kura Oncology Inc	7.54	$ 79.314 Millions	$ 10.521 Millions
Merit Medical Systems Inc	7.53	$ 1,612.236 Millions	$ 214.065 Millions
Cerus Corporation	7.48	$ 226.798 Millions	$ 30.308 Millions
Insmed Inc	7.45	$ 1,479.040 Millions	$ 198.502 Millions
Novocure Limited	7.44	$ 725.388 Millions	$ 97.525 Millions
Edap Tms Sa	7.44	$ 111.370 Millions	$ 14.974 Millions
Intuitive Surgical Inc	7.44	$ 12,115.600 Millions	$ 1,629.350 Millions
Quest Diagnostics Inc	7.43	$ 11,841.000 Millions	$ 1,593.250 Millions
Halozyme Therapeutics Inc	7.42	$ 1,802.448 Millions	$ 242.980 Millions
Sanuwave Health Inc	7.40	$ 41.031 Millions	$ 5.547 Millions
Transmedics Group Inc	7.39	$ 727.650 Millions	$ 98.521 Millions
Septerna Inc	7.37	$ 96.268 Millions	$ 13.061 Millions
Travere Therapeutics Inc	7.32	$ 651.034 Millions	$ 88.900 Millions
Liquidia Corporation	7.24	$ 621.865 Millions	$ 85.896 Millions
Si bone inc	7.19	$ 222.189 Millions	$ 30.881 Millions
Aurinia Pharmaceuticals Inc	7.18	$ 321.738 Millions	$ 44.795 Millions
Beta Bionics Inc	7.15	$ 127.899 Millions	$ 17.897 Millions
Tarsus Pharmaceuticals Inc	7.15	$ 682.203 Millions	$ 95.466 Millions
Angiodynamics Inc	7.13	$ 323.784 Millions	$ 45.418 Millions
Stryker Corp	6.99	$ 26,300.000 Millions	$ 3,761.500 Millions
Boston Scientific Corporation	6.96	$ 21,070.000 Millions	$ 3,028.750 Millions

Date modified: 2026-11-11T13:46:55+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.